trial

Examining Persistence in Smokers With Schizophrenia

NCTId NCT03346291
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 27 (actual)
Sponsored by Rutgers, The State University of New Jersey
Primary completion 2018-06-13
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
27 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2017-01
Primary completion
2018-06-13
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
counseling

Sponsors

Rutgers, The State University of New JerseyLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Marc L. Steinberg, PH.D.Principal Investigator

Sites

1 total
New Brunswick, United States

Facts & assertions

4 sourced
Enrollment
27
Phase
NA
Primary Completion Date
2018-06-13
Status
COMPLETED
relationships
The graph out of here
drug
counseling
drug
lead_sponsor
Rutgers, The State University of New Jersey
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Schizo Affective Disorder
indication
Psychotic Disorders
indication
Smoking Cessation
indication
investigator
Marc L. Steinberg, PH.D.
person